Home›People›Robert Hillman, Ph.D.
RD

Robert Hillman, Ph.D.

President and CEO, director at CeleCor Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Jul 9, 2026·Suggest an edit

About Robert Hillman, Ph.D.

Robert Hillman, Ph.D. is a president and CEO, director at CeleCor Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Robert Hillman, Ph.D. in the role, so the role may have started earlier or lasted longer.

CeleCor Therapeutics, Inc.
President and CEO, director
2026 · Del Mar, CA
Develops an investigational drug for early treatment of severe heart attacks.

Key Colleagues at Startups

The people Robert Hillman, Ph.D. works with at each company, as listed on that company's latest Form D.

CeleCor Therapeutics, Inc. · Form D, Jul 9, 2026
PF
Peter Finn
Secretary
JL
Jack Lief
Director
AR

Sources

  1. SECCeleCor Therapeutics, Inc. Form D, filed Jul 9, 2026